Potent σ1-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine provides ischemic neuroprotection without altering dopamine accumulation in vivo in rats

Toru Goyagi, Anish Bhardwaj, Raymond C. Koehler, Richard J. Traystman, Patricia D. Hurn, Jeffrey R. Kirsch

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

The in vivo signaling of ischemic neuroprotection provided by σ-receptor ligands remains unclear. Catecholamines have been implicated in the propagation of ischemic neuronal injury, and previous in vitro studies suggest that σ ligands modulate dopaminergic neurotransmission. In this study, we tested the hypothesis that the potent σ1-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP) attenuates the increase of extracellular dopamine in ischemic striatum. Under controlled physiological conditions, a microdialysis probe was implanted in right caudoputamen (CP) complex of adult male Wistar rats. Rats were subjected to 2 h of transient middle cerebral artery occlusion (MCAO) by the intraluminal suture technique. In a blinded, randomized fashion, rats were divided into five treatment groups: Group 1 (n = 8; saline-saline) continuous IV infusion of saline vehicle 30 min before MCAO followed by saline at reperfusion until the end of the experiment; Group 2 (n = 8; PPBP-PPBP) IV PPBP 30 min before MCAO followed by 1 μmol · kg-1 · h-1 of PPBP; Group 3 (n = 8; saline-PPBP) IV saline before MCAO followed by PPBP; Group 4 (n = 4) surgical shams (saline-saline); and Group 5 (n = 4) surgical shams (PPBP-PPBP). Infarction volume at 22 h of reperfusion in the CP complex (percentage of ipsilateral structure) was significantly attenuated in rats treated with PPBP-PPBP (27.3% ± 9.1%) and saline-PPBP (27.8% ± 12.7%) compared with saline-saline (59.3% ± 73%) treatment. There was a three- to fourfold increase in dopamine concentrations in the microdialysates within 40 min of the onset of MCAO. Dopamine and its metabolites dihydroxy phenylacetic acid and homovallinic acid levels were similar among the three groups subjected to MCAO. Therefore, PPBP provides significant ischemic neuroprotection in the CP complex without altering the acute accumulation of dopamine in vivo during transient focal ischemia in the rat.

Original languageEnglish (US)
Pages (from-to)532-538
Number of pages7
JournalAnesthesia and Analgesia
Volume96
Issue number2
DOIs
StatePublished - Feb 1 2003
Externally publishedYes

Fingerprint

Middle Cerebral Artery Infarction
Dopamine
Ligands
Reperfusion
Suture Techniques
Microdialysis
Synaptic Transmission
Infarction
Catecholamines
4-phenyl-1-(4-phenylbutyl)piperidine
Neuroprotection
Wistar Rats
Ischemia
Acids
Wounds and Injuries

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Potent σ1-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine provides ischemic neuroprotection without altering dopamine accumulation in vivo in rats. / Goyagi, Toru; Bhardwaj, Anish; Koehler, Raymond C.; Traystman, Richard J.; Hurn, Patricia D.; Kirsch, Jeffrey R.

In: Anesthesia and Analgesia, Vol. 96, No. 2, 01.02.2003, p. 532-538.

Research output: Contribution to journalArticle

Goyagi, Toru ; Bhardwaj, Anish ; Koehler, Raymond C. ; Traystman, Richard J. ; Hurn, Patricia D. ; Kirsch, Jeffrey R. / Potent σ1-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine provides ischemic neuroprotection without altering dopamine accumulation in vivo in rats. In: Anesthesia and Analgesia. 2003 ; Vol. 96, No. 2. pp. 532-538.
@article{c9e4728b44ff48619a796e4aa0ef47a4,
title = "Potent σ1-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine provides ischemic neuroprotection without altering dopamine accumulation in vivo in rats",
abstract = "The in vivo signaling of ischemic neuroprotection provided by σ-receptor ligands remains unclear. Catecholamines have been implicated in the propagation of ischemic neuronal injury, and previous in vitro studies suggest that σ ligands modulate dopaminergic neurotransmission. In this study, we tested the hypothesis that the potent σ1-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP) attenuates the increase of extracellular dopamine in ischemic striatum. Under controlled physiological conditions, a microdialysis probe was implanted in right caudoputamen (CP) complex of adult male Wistar rats. Rats were subjected to 2 h of transient middle cerebral artery occlusion (MCAO) by the intraluminal suture technique. In a blinded, randomized fashion, rats were divided into five treatment groups: Group 1 (n = 8; saline-saline) continuous IV infusion of saline vehicle 30 min before MCAO followed by saline at reperfusion until the end of the experiment; Group 2 (n = 8; PPBP-PPBP) IV PPBP 30 min before MCAO followed by 1 μmol · kg-1 · h-1 of PPBP; Group 3 (n = 8; saline-PPBP) IV saline before MCAO followed by PPBP; Group 4 (n = 4) surgical shams (saline-saline); and Group 5 (n = 4) surgical shams (PPBP-PPBP). Infarction volume at 22 h of reperfusion in the CP complex (percentage of ipsilateral structure) was significantly attenuated in rats treated with PPBP-PPBP (27.3{\%} ± 9.1{\%}) and saline-PPBP (27.8{\%} ± 12.7{\%}) compared with saline-saline (59.3{\%} ± 73{\%}) treatment. There was a three- to fourfold increase in dopamine concentrations in the microdialysates within 40 min of the onset of MCAO. Dopamine and its metabolites dihydroxy phenylacetic acid and homovallinic acid levels were similar among the three groups subjected to MCAO. Therefore, PPBP provides significant ischemic neuroprotection in the CP complex without altering the acute accumulation of dopamine in vivo during transient focal ischemia in the rat.",
author = "Toru Goyagi and Anish Bhardwaj and Koehler, {Raymond C.} and Traystman, {Richard J.} and Hurn, {Patricia D.} and Kirsch, {Jeffrey R.}",
year = "2003",
month = "2",
day = "1",
doi = "10.1097/00000539-200302000-00043",
language = "English (US)",
volume = "96",
pages = "532--538",
journal = "Anesthesia and Analgesia",
issn = "0003-2999",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Potent σ1-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine provides ischemic neuroprotection without altering dopamine accumulation in vivo in rats

AU - Goyagi, Toru

AU - Bhardwaj, Anish

AU - Koehler, Raymond C.

AU - Traystman, Richard J.

AU - Hurn, Patricia D.

AU - Kirsch, Jeffrey R.

PY - 2003/2/1

Y1 - 2003/2/1

N2 - The in vivo signaling of ischemic neuroprotection provided by σ-receptor ligands remains unclear. Catecholamines have been implicated in the propagation of ischemic neuronal injury, and previous in vitro studies suggest that σ ligands modulate dopaminergic neurotransmission. In this study, we tested the hypothesis that the potent σ1-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP) attenuates the increase of extracellular dopamine in ischemic striatum. Under controlled physiological conditions, a microdialysis probe was implanted in right caudoputamen (CP) complex of adult male Wistar rats. Rats were subjected to 2 h of transient middle cerebral artery occlusion (MCAO) by the intraluminal suture technique. In a blinded, randomized fashion, rats were divided into five treatment groups: Group 1 (n = 8; saline-saline) continuous IV infusion of saline vehicle 30 min before MCAO followed by saline at reperfusion until the end of the experiment; Group 2 (n = 8; PPBP-PPBP) IV PPBP 30 min before MCAO followed by 1 μmol · kg-1 · h-1 of PPBP; Group 3 (n = 8; saline-PPBP) IV saline before MCAO followed by PPBP; Group 4 (n = 4) surgical shams (saline-saline); and Group 5 (n = 4) surgical shams (PPBP-PPBP). Infarction volume at 22 h of reperfusion in the CP complex (percentage of ipsilateral structure) was significantly attenuated in rats treated with PPBP-PPBP (27.3% ± 9.1%) and saline-PPBP (27.8% ± 12.7%) compared with saline-saline (59.3% ± 73%) treatment. There was a three- to fourfold increase in dopamine concentrations in the microdialysates within 40 min of the onset of MCAO. Dopamine and its metabolites dihydroxy phenylacetic acid and homovallinic acid levels were similar among the three groups subjected to MCAO. Therefore, PPBP provides significant ischemic neuroprotection in the CP complex without altering the acute accumulation of dopamine in vivo during transient focal ischemia in the rat.

AB - The in vivo signaling of ischemic neuroprotection provided by σ-receptor ligands remains unclear. Catecholamines have been implicated in the propagation of ischemic neuronal injury, and previous in vitro studies suggest that σ ligands modulate dopaminergic neurotransmission. In this study, we tested the hypothesis that the potent σ1-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP) attenuates the increase of extracellular dopamine in ischemic striatum. Under controlled physiological conditions, a microdialysis probe was implanted in right caudoputamen (CP) complex of adult male Wistar rats. Rats were subjected to 2 h of transient middle cerebral artery occlusion (MCAO) by the intraluminal suture technique. In a blinded, randomized fashion, rats were divided into five treatment groups: Group 1 (n = 8; saline-saline) continuous IV infusion of saline vehicle 30 min before MCAO followed by saline at reperfusion until the end of the experiment; Group 2 (n = 8; PPBP-PPBP) IV PPBP 30 min before MCAO followed by 1 μmol · kg-1 · h-1 of PPBP; Group 3 (n = 8; saline-PPBP) IV saline before MCAO followed by PPBP; Group 4 (n = 4) surgical shams (saline-saline); and Group 5 (n = 4) surgical shams (PPBP-PPBP). Infarction volume at 22 h of reperfusion in the CP complex (percentage of ipsilateral structure) was significantly attenuated in rats treated with PPBP-PPBP (27.3% ± 9.1%) and saline-PPBP (27.8% ± 12.7%) compared with saline-saline (59.3% ± 73%) treatment. There was a three- to fourfold increase in dopamine concentrations in the microdialysates within 40 min of the onset of MCAO. Dopamine and its metabolites dihydroxy phenylacetic acid and homovallinic acid levels were similar among the three groups subjected to MCAO. Therefore, PPBP provides significant ischemic neuroprotection in the CP complex without altering the acute accumulation of dopamine in vivo during transient focal ischemia in the rat.

UR - http://www.scopus.com/inward/record.url?scp=0037302002&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037302002&partnerID=8YFLogxK

U2 - 10.1097/00000539-200302000-00043

DO - 10.1097/00000539-200302000-00043

M3 - Article

VL - 96

SP - 532

EP - 538

JO - Anesthesia and Analgesia

JF - Anesthesia and Analgesia

SN - 0003-2999

IS - 2

ER -